Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission [Phase 2]
Phase 2 clinical trial evaluating chemo-sensitization before hematopoietic stem cell transplantation in patients with acute leukemia who are…
-
FDA approval · 2020-01-13FDA Approved: VYXEOS — Supplemental Application (Jazz Pharmaceuticals, Inc.)
FDA approves a supplemental application for VYXEOS (daunorubicin and cytarabine liposome) from Jazz Pharmaceuticals, expanding its approved …
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating idarubicin, cytarabine, and pravastatin for relapsed acute myeloid leukemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT [Phase 2]
Phase 2 clinical trial evaluating irradiation-based myeloablative conditioning followed by regulatory T cell and conventional T cell immunot…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease [Phase 1]
Phase 1 trial evaluating lenalidomide after allogeneic hematopoietic cell transplant in AML and MDS patients with minimal residual disease; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial evaluating erlotinib hydrochloride in relapsed or refractory acute myeloid leukemia has completed with posted results…
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation [Phase 2]
Phase 2 trial evaluating sorafenib in combination with 5-azacitidine as initial therapy for AML and high-risk MDS with FLT3-ITD mutation; tr…
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Comparing the Consolidation Regimens of IDA With Intermediate-dose Cytarabine Versus Intermediate-dose Cytarabine Alone for Elderly AML Patients [Phase 2, Phase 3]
A clinical trial update comparing consolidation regimens of IDA with intermediate-dose cytarabine versus intermediate-dose cytarabine alone …
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: CD123/CLL1 CAR-T Cells for R/R AML (STPHI_0001) [Phase 2, Phase 3]
A clinical trial update for CD123/CLL1 CAR-T cells in relapsed/refractory acute myeloid leukemia (AML) in Phase 2/Phase 3.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 trial of a liposome-encapsulated combination therapy for younger patients with relapsed or refractory acute myeloid leukemia, comp…
-
CLINICAL_TRIALS trial_result · 2019-12-27Clinical Trial Update: Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 open-label study evaluating safety and efficacy of two doses of quizartinib in relapsed or refractory acute myeloid leukemia has com…
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Home Away From Home - Medical Outcomes
Completed clinical trial update for a study involving acute myeloid leukemia and neutropenia with mention of bacteremia results.
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Home Away From Home - Quality of Life Surveys
A completed clinical trial focusing on quality of life surveys in pediatric patients with acute myeloid leukemia; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating total-body irradiation and fludarabine phosphate followed by donor peripheral blood stem cell transpla…
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: A Study of Safety, Efficacy and Pharmacodynamics of Azacitidine in Children and Young Adults With Acute Myeloid Leukemia. [Phase 2]
A Phase 2 clinical trial assessing safety, efficacy, and pharmacodynamics of azacitidine in children and young adults with acute myeloid leu…
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 [Phase 1, Phase 2]
Phase 1/2 trial evaluating CART133 for relapsed/chemo-refractory advanced malignancies completed, across multiple cancers.
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases [Phase 2]
Phase 2 trial update on NK cell–based non-myeloablative transplantation for acute myeloid diseases, including acute myeloid leukemia and mye…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections [Phase 4]
Phase 4 clinical trial update reporting pharmacokinetics of posaconazole (Noxafil) when used as prophylaxis for invasive fungal infections i…
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation. [Phase 2]
Phase 2 clinical trial evaluating azacytidine and lymphocytes in relapse of acute myeloid leukemia or myelodysplastic syndrome after allogen…
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant [Phase 2]
Phase 2 trial investigating sirolimus, cyclosporine, and mycophenolate mofetil to prevent graft-versus-host disease in patients with blood c…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 clinical trial results update for AC220 in treating Acute Myeloid Leukemia has been completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: An Exercise Trial for Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy [Phase 2]
Phase 2 clinical trial investigating an exercise program for patients with acute myeloid leukemia undergoing induction chemotherapy has comp…
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 clinical trial assessing donor atorvastatin to prevent severe acute GVHD after nonmyeloablative peripheral blood stem cell transplan…
-
CLINICAL_TRIALS trial_result · 2019-11-21Clinical Trial Update: Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Phase 1/2 trial evaluating PLX3397 in adults with relapsed or refractory acute myeloid leukemia completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Clinical trial update for Entospletinib as monotherapy and in combination with chemotherapy in adults with Acute Myeloid Leukemia; the study…